
CMS has selected Bioscrip as the first national vendor for the newCompetitive Acquisition Program (CAP) for certain Medicare Part Bdrugs and biologicals beginning July 1. Participating physicianswill acquire the drugs from Bioscrip and administer them tobeneficiaries instead of purchasing them from distributors andbeing reimbursed by Medicare.